Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
Copyright © 2023 Elsevier Inc. All rights reserved..
INTRODUCTION: Upper tract urothelial carcinoma is rare but has a poor prognosis. Prognostic factors have been extensively studied in order to provide the best possible management for patients. We have aimed to investigate commonly available factors predictive of recurrence and survival in this patient population at high risk of death and recurrence, with an emphasis on the effects of age (using a cutoff of 70 years) on survival outcomes.
PATIENTS AND METHODS: From 1387 patients with clinically nonmetastatic upper tract urothelial carcinoma treated with radical nephroureterectomy at 21 academic hospital centers between 2005 and 2021, 776 patients were eligible and included in the study. Univariable and multivariable Cox regression models were built to evaluate the independent prognosticators for intravesical and extravesical recurrence, overall survival, and cancer-specific survival according to age groups. A P value of <.05 was considered statistically significant.
RESULTS: We did not find an association between groups aged <70 and >70 years old and preoperatively clinical or histopathological characteristics. Kaplan-Meier analysis was found no statistical significance between the 2 age groups in terms of intravesical or extravesical recurrence (P = .09 and P = .57). Overall survival (P = .0001) and cancer-specific survival (P = .0001) have been found to be statistically significantly associated with age as independent predictors (confounding factors: gender, tumor size, tumor side, clinical T stage, localization, preoperative hydronephrosis, tumor localization, type of surgery, multifocality of the tumor, pathological grade, lymphovascular invasion, concomitant CIS, lymph node status, necrosis, or history of previous bladder cancer).
CONCLUSION: This research confirms that patients aged 70 and above who undergo radical nephroureterectomy may have worse outcomes compared to younger patients, older patients needing an improved care and management of UTUC to improve their outcomes in the setting of an increase in this aged population group.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Clinical genitourinary cancer - 22(2024), 2 vom: 30. Apr., Seite 27-37 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Cancer-specific survival |
|---|
| Anmerkungen: |
Date Completed 11.03.2024 Date Revised 09.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.clgc.2023.08.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361592256 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361592256 | ||
| 003 | DE-627 | ||
| 005 | 20240410232213.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clgc.2023.08.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1371.xml |
| 035 | |a (DE-627)NLM361592256 | ||
| 035 | |a (NLM)37661507 | ||
| 035 | |a (PII)S1558-7673(23)00184-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ferro, Matteo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2024 | ||
| 500 | |a Date Revised 09.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
| 520 | |a INTRODUCTION: Upper tract urothelial carcinoma is rare but has a poor prognosis. Prognostic factors have been extensively studied in order to provide the best possible management for patients. We have aimed to investigate commonly available factors predictive of recurrence and survival in this patient population at high risk of death and recurrence, with an emphasis on the effects of age (using a cutoff of 70 years) on survival outcomes | ||
| 520 | |a PATIENTS AND METHODS: From 1387 patients with clinically nonmetastatic upper tract urothelial carcinoma treated with radical nephroureterectomy at 21 academic hospital centers between 2005 and 2021, 776 patients were eligible and included in the study. Univariable and multivariable Cox regression models were built to evaluate the independent prognosticators for intravesical and extravesical recurrence, overall survival, and cancer-specific survival according to age groups. A P value of <.05 was considered statistically significant | ||
| 520 | |a RESULTS: We did not find an association between groups aged <70 and >70 years old and preoperatively clinical or histopathological characteristics. Kaplan-Meier analysis was found no statistical significance between the 2 age groups in terms of intravesical or extravesical recurrence (P = .09 and P = .57). Overall survival (P = .0001) and cancer-specific survival (P = .0001) have been found to be statistically significantly associated with age as independent predictors (confounding factors: gender, tumor size, tumor side, clinical T stage, localization, preoperative hydronephrosis, tumor localization, type of surgery, multifocality of the tumor, pathological grade, lymphovascular invasion, concomitant CIS, lymph node status, necrosis, or history of previous bladder cancer) | ||
| 520 | |a CONCLUSION: This research confirms that patients aged 70 and above who undergo radical nephroureterectomy may have worse outcomes compared to younger patients, older patients needing an improved care and management of UTUC to improve their outcomes in the setting of an increase in this aged population group | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cancer-specific survival | |
| 650 | 4 | |a Elderly patients | |
| 650 | 4 | |a Multicenter study | |
| 650 | 4 | |a Overall survival | |
| 650 | 4 | |a Upper urothelial carcinoma | |
| 700 | 1 | |a Chiujdea, Sever |e verfasserin |4 aut | |
| 700 | 1 | |a Vartolomei, Mihai Dorin |e verfasserin |4 aut | |
| 700 | 1 | |a Bove, Pierluigi |e verfasserin |4 aut | |
| 700 | 1 | |a Porreca, Angelo |e verfasserin |4 aut | |
| 700 | 1 | |a Busetto, Gian Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Del Giudice, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Antonelli, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Foschi, Nazario |e verfasserin |4 aut | |
| 700 | 1 | |a Racioppi, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Autorino, Riccardo |e verfasserin |4 aut | |
| 700 | 1 | |a Chiancone, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Longo, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Barone, Biagio |e verfasserin |4 aut | |
| 700 | 1 | |a Crocetto, Felice |e verfasserin |4 aut | |
| 700 | 1 | |a Musi, Gennaro |e verfasserin |4 aut | |
| 700 | 1 | |a Luzzago, Stefano |e verfasserin |4 aut | |
| 700 | 1 | |a Piccinelli, Mattia Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Mistretta, Francesco Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a de Cobelli, Ottavio |e verfasserin |4 aut | |
| 700 | 1 | |a Tataru, Octavian Sabin |e verfasserin |4 aut | |
| 700 | 1 | |a Hurle, Rodolfo |e verfasserin |4 aut | |
| 700 | 1 | |a Liguori, Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Borghesi, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Veccia, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Greco, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Schips, Luigi |e verfasserin |4 aut | |
| 700 | 1 | |a Marchioni, Michele |e verfasserin |4 aut | |
| 700 | 1 | |a Lucarelli, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Dutto, Daniele |e verfasserin |4 aut | |
| 700 | 1 | |a Colucci, Fulvia |e verfasserin |4 aut | |
| 700 | 1 | |a Russo, Giorgio Ivan |e verfasserin |4 aut | |
| 700 | 1 | |a Giudice, Arturo Lo |e verfasserin |4 aut | |
| 700 | 1 | |a Montanari, Emanuele |e verfasserin |4 aut | |
| 700 | 1 | |a Boeri, Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Simone, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Rosazza, Matteo |e verfasserin |4 aut | |
| 700 | 1 | |a Livoti, Simone |e verfasserin |4 aut | |
| 700 | 1 | |a Gontero, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Soria, Francesco |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical genitourinary cancer |d 2005 |g 22(2024), 2 vom: 30. Apr., Seite 27-37 |w (DE-627)NLM160229936 |x 1938-0682 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2024 |g number:2 |g day:30 |g month:04 |g pages:27-37 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clgc.2023.08.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2024 |e 2 |b 30 |c 04 |h 27-37 | ||